These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical trials in recurrent ovarian cancer. Friedlander M; Trimble E; Tinker A; Alberts D; Avall-Lundqvist E; Brady M; Harter P; Pignata S; Pujade-Lauraine E; Sehouli J; Vergote I; Beale P; Bekkers R; Calvert P; Copeland L; Glasspool R; Gonzalez-Martin A; Katsaros D; Kim JW; Miller B; Provencher D; Rubinstein L; Atri M; Zeimet A; Bacon M; Kitchener H; Stuart GC; Int J Gynecol Cancer; 2011 May; 21(4):771-5. PubMed ID: 21543939 [TBL] [Abstract][Full Text] [Related]
11. Targeted therapies for treatment of recurrent ovarian cancer. Grisham RN; Hyman DM; Iyer G Clin Adv Hematol Oncol; 2014 Mar; 12(3):158-62. PubMed ID: 24927263 [TBL] [Abstract][Full Text] [Related]
12. The role of targeted therapy in ovarian cancer. Banerjee S; Kaye S Eur J Cancer; 2011 Sep; 47 Suppl 3():S116-30. PubMed ID: 21943965 [TBL] [Abstract][Full Text] [Related]
13. MMPs in ovarian cancer as therapeutic targets. Karam A; Dorigo O Anticancer Agents Med Chem; 2012 Sep; 12(7):764-72. PubMed ID: 22292752 [TBL] [Abstract][Full Text] [Related]
14. Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer. Weberpals JI; Koti M; Squire JA Cancer Genet; 2011 Oct; 204(10):525-35. PubMed ID: 22137482 [TBL] [Abstract][Full Text] [Related]
15. Targeted molecular therapies for ovarian cancer: an update and future perspectives (Review). Shigetomi H; Higashiura Y; Kajihara H; Kobayashi H Oncol Rep; 2012 Aug; 28(2):395-408. PubMed ID: 22641286 [TBL] [Abstract][Full Text] [Related]
17. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development. Hollebecque A; Massard C; Soria JC Curr Opin Oncol; 2014 May; 26(3):340-6. PubMed ID: 24709975 [TBL] [Abstract][Full Text] [Related]
18. Development of anti-cancer drugs. Arrondeau J; Gan HK; Razak AR; Paoletti X; Le Tourneau C Discov Med; 2010 Oct; 10(53):355-62. PubMed ID: 21034677 [TBL] [Abstract][Full Text] [Related]
19. Targeted agents in ovarian cancer. Kristedja TS; Morgan RJ; Cristea M Womens Health (Lond); 2010 Sep; 6(5):679-94. PubMed ID: 20887168 [TBL] [Abstract][Full Text] [Related]
20. Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy. Gong H; Nie D; Li Z Curr Cancer Drug Targets; 2020; 20(11):853-867. PubMed ID: 32807056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]